And I'm wondering now if the calimmune trial scheduled to
run in both Sydney and LA is for the pure shRNA
drug?
I like the fact Calimmune and gradalis, both using
shRNA, say little yet have already arrived at clinical
trials - in direct contrast to the huge fanfare Alnylam
have made for the last 8 years over what amounts to
no greater clinical progress in less critical diseases.
